Nat Prod Sci.  2016 Jun;22(2):140-145. 10.20307/nps.2016.22.2.140.

Phenolic Constituents and Their Anti-inflammatory Activity from Echinochloa utilis Grains

Affiliations
  • 1College of Pharmacy, Catholic University of Daegu, Gyeongsan 38430, Republic of Korea. woomh@cu.ac.kr
  • 2Laboratory of Immunobiology, School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 39061, Republic of Korea.
  • 3Functional Cereal Crop research Division, Department of Functional Crop, NICS, RDA, 50426, Republic of Korea.
  • 4Phu Tho College of Pharmacy, Viettri City, Phutho Province 290000, Vietnam.

Abstract

Seven phenolic compounds including p-coumaric acid (1), 4-hydroxybenzoic acid (2), 4-hydroxybenzaldehyde (3), vanillic acid (4), luteolin (5), acacetin (6), and tricin (7), were isolated from the methylene chloride and ethyl acetate fractions of Echinochloa utilis grains. Compounds (1 - 4, 6) were isolated for the first time from this plant. These compounds were tested for inhibitory activities against LPS-induced NO production in RAW 264.7 cells. Compounds 5 and 6 displayed significant inhibitory effects, with ICâ‚…â‚€ values of 27.9 ± 2.6 and 14.0 ± 1.1 µM, respectively. The results suggested that E. utilis ethanolic extract may be used as a potential source of anti-inflammatory agents and functional foods for the treatment of allergic diseases.

Keyword

Echinochloa utilis; Phenolic compounds; NO production

MeSH Terms

Anti-Inflammatory Agents
Echinochloa*
Ethanol
Functional Food
Luteolin
Methylene Chloride
Phenol*
Plants
RAW 264.7 Cells
Vanillic Acid
Anti-Inflammatory Agents
Ethanol
Luteolin
Methylene Chloride
Phenol
Vanillic Acid

Figure

  • Fig. 1. Chemical structures of compounds 1–7 isolated from the grains of E. utilis.

  • Fig. 2. The effects of compounds 5 and 6 on LPS-induced rise of iNOS and COX-2 levels in RAW 264.7 cells. The RAW 264.7 cells were pretreated with LPS (0.1 µg/mL) for 30 min, followed by concentrations of 2.5, 5.0, and 10.0 µg/mL for 5 and 1.25, 2.5, and 5.0 µg/mL for 6 for 24 h. Whole-cell lysates were blotted with the indicated antibodies. β-Actin level was used as a loading control. The expressions of iNOS and COX-2 were assessed by Western blotting analysis using specific antibodies for individual proteins. The results are representatives of three independent experiments.


Reference

(1). Zedler S., Faist E.Curr. Opin. Crit. Care. 2006; 12:595–601.
(2). Mariathasan S., Monack D. M.Nat. Rev. Immunol. 2007; 7:31–40.
(3). Korhonen R., Lahti A., Kankaanranta H., Moilanen E.Curr. Drug Targets Inflamm. Allergy. 2005; 4:471–479.
(4). Salvemini D., Ischiropoulos H., Cuzzocrea S.Methods Mol. Biol. 2003; 225:291–303.
(5). Yabuno T.Econ. Bot. 1987; 41:484–493.
(6). Nozawa S., Takahashi M., Nakai H., Sato Y.Breed. Sci. 2006; 56:335–340.
(7). Park K.Y., Park R. K., Choi B. H.Korean J. Crop Sci. 1991; 36:249–253.
(8). Kim J. Y., Jang K. C., Park B. R., Han S. I., Choi K. J., Kim S. Y., Oh S. H., Ra J. E., Ha T. J., Lee J. H., Hwang J. Y., Kang H. W., Seo W. D.Food Sci. Biotechnol. 2011; 20:461–469.
(9). Watanabe M. J.Agric. Food Chem. 1999; 47:4500–4505.
(10). Migliorini P., Corradin G., Corradin S. B. J.Immunol. Methods. 1991; 139:107–114.
(11). Lee Y. J., Han J. Y., Lee C. G., Heo K., Park S. I., Park Y. S., Kim J. S., Yang K. M., Lee K. J., Kim T. H., Rhee M. H., Kim S. D. J.Ginseng Res. 2014; 38:208–214.
(12). Yang J., Wang D., Liu W., Zhang X., Bian F., Yu W.Green Chem. 2013; 15:3429–3437.
(13). Yayli N., Yildirim N., Usta A., Özkurt S., Akgün V., Turk J.Chem. 2003; 27:749–756.
(14). Xu M. L., Wang L., Hu J. H., Wang M. H. J.Food Sci. Nutr. 2009; 14:354–357.
(15). Chang S. W., Kim K. H., Lee I. K., Choi S. U., Ryu S. Y., Lee K. R.Nat. Prod. Sci. 2009; 15:234–240.
(16). Wagner H., Chari V. M., Sonnenbichler J.Tetrahedron Lett. 1976; 17:1799–1802.
(17). Shimoi K., Masuda S., Furugori M., Esaki S., Kinae N.Carcinogenesis. 1994; 15:2669–2672.
(18). Yamamoto H., Sakakibara J., Nagatsu A., Sekiya K. J.Agric. Food Chem. 1998; 46:862–865.
(19). Lin Y., Shi R., Wang X., Shen H. M.Curr. Cancer Drug Targets. 2008; 8:634–646.
(20). Seelinger G., Merfort I., Schempp C. M.Planta Med. 2008; 74:1667–1677.
(21). Park C. M., Song Y. S.Nutr. Res. Pract. 2013; 7:423–429.
(22). Yang Z. G., Jia L. N., Shen Y., Ohmura A., Kitanaka S.Molecules. 2011; 16:8305–8318.
(23). Chan T. S., Galati G., Pannala A. S., Rice-Evans C., O'Brien P. J.Free Radic. Res. 2003; 37:787–794.
(24). Pan M. H., Lai C. S., Wang Y. J., Ho C. T.Biochem. Pharmacol. 2006; 72:1293–1303.
(25). Srisook K., Srisook E., Nachaiyo W., Chan-In M., Thongbai J., Wongyoo K., Chawsuanthong S., Wannasri K., Intasuwan S., Watcharanawee K. J.Ethnopharmacol. 2015; 165:94–102.
Full Text Links
  • NPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr